X0206 3 2020-02-26 0 0001434868 Esperion Therapeutics, Inc. ESPR 0001801842 Hall Ashley C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 0 1 0 0 Chief Development Officer Common Stock 10000 D Common Stock 5500 D Stock Option (right to buy) 57.54 2025-08-19 Common Stock 150000 D Stock Option (right to buy) 21.65 2026-01-04 Common Stock 20000 D Stock Option (right to buy) 12.88 2027-01-03 Common Stock 27000 D Stock Option (right to buy) 24.42 2027-02-21 Common Stock 100000 D Stock Option (right to buy) 66.50 2028-01-02 Common Stock 14000 D Stock Option (right to buy) 52.38 2028-11-28 Common Stock 30000 D Stock Option (right to buy) 61.34 2030-01-02 Common Stock 24750 D These shares were acquired pursuant to a restricted stock unit award under the Amended and Restated 2013 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Esperion Therapeutics, Inc. common stock. The restricted stock units vest over a four (4) year period in equal quarterly installments, the first of which will be on April 2, 2020. The options are fully vested as of the date hereof. The options vest over a four (4) year period in equal quarterly installments, the first of which was on April 3, 2017. The options vest over a four (4) year period in equal quarterly installments, the first of which was on May 21, 2017. The options vest over a four (4) year period in equal quarterly installments, the first of which was on April 2, 2018. The options vest over a four (4) year period in equal quarterly installments, the first of which was on February 28, 2019. The options vest over a four (4) year period in equal quarterly installments, the first of which will be on April 2, 2020. /s/ Richard B. Bartram, by power of attorney 2020-02-28